Biocartis Group NV (EBR:BCART)
Belgium · Delayed Price · Currency is EUR 0.2900
0.00 (0.00%)
At close: Sep 17, 2025
Biocartis Group NV Market Cap
Biocartis Group NV has a market cap or net worth of €27.24 million as of September 18, 2025.
Market Cap
27.24M
Enterprise Value
26.59M
Revenue
47.69M
Ranking
n/a
PE Ratio
1.48
Stock Price
€0.29
Market Cap Chart
Since April 27, 2015, Biocartis Group NV's market cap has decreased from 525.83M to 27.24M, a decrease of -94.82%. That is a compound annual growth rate of -24.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2025 | 27.24M | - |
| Dec 31, 2024 | 27.24M | - |
| Dec 29, 2023 | 27.24M | -43.87% |
| Dec 30, 2022 | 48.52M | -76.68% |
| Dec 31, 2021 | 208.03M | -22.26% |
| Dec 31, 2020 | 267.59M | -17.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 38.57B |
| argenx SE | 38.38B |
| Financière de Tubize | 7.36B |
| Fagron NV | 1.43B |
| Ion Beam Applications | 323.69M |
| Onward Medical | 229.92M |
| Hyloris Pharmaceuticals | 170.80M |
| Nyxoah | 147.87M |